Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Memphasys Ltd ( (AU:MEM) ).
Memphasys Limited has announced a change in the venue for its upcoming General Meeting, scheduled for 8 August 2025. The meeting will now be held at Level 32/200 George Street, and shareholders can participate by lodging proxy forms or attending in person. This change does not affect any other details previously released about the meeting.
More about Memphasys Ltd
Memphasys Limited (ASX: MEM) is a biotechnology company that focuses on advanced reproductive biotechnology. It develops medical devices, diagnostics, and proprietary media for both human and animal applications. The company is known for its flagship technologies, the Felix ™ and RoXsta ™ Systems, which aim to enhance fertility outcomes globally.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$9.92M
See more data about MEM stock on TipRanks’ Stock Analysis page.